Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

Author: MP Chin, GL Bakris, GA Block, GM Chertow, et al.

Year Published: 2018

Media Outlet: American Journal of Nephrology

Open Access? No

Matrix:

Biological Themes:

Product(s):

Access Publication

Cited in over 3,000 publications, we help scientists and manufacturers gain greater insight into their studies through metabolomics.

Browse All Publications

GET STARTED

Talk with an expert

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.

Find us on:

Talk with a Metabolomics expert

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Industry(Required)

Country(Required)

State(Required)

Territory(Required)

ZIP/Postal Code(Required)

Enquiry Type(Required)

Message

Marketing Opt-in

I would like to receive information from Metabolon

By submitting this form, you agree to our Terms of Use, Privacy Policy, and Cookie Policy.

This field is hidden when viewing the form

FormSubmittedURL

This field is hidden when viewing the form

UTM Medium

This field is hidden when viewing the form

UTM Source

This field is hidden when viewing the form

UTM Campaign

This field is hidden when viewing the form

UTM Content

This field is hidden when viewing the form

UTM Term

This field is hidden when viewing the form

GLCID

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

Talk with an expert

Talk with a Metabolomics expert

Software

Services

Applications

Learn

Company

Newsletter